Complete response of a hepatocellular carcinoma with complex macrovascular invasion after combined treatment with chemoembolization and immunotherapy: a case report

Author:

Bucalau A.-M.,Tancredi I,Pezzullo M,Covas A,Verset G

Abstract

Hepatocellular carcinoma accounts for 90% of primary liver cancers and represents a growing health problem worldwide. We report the complex case of a 71 year-old patient diagnosed with a large hepatocellular carcinoma and presenting an extensive vascular invasion of the middle hepatic vein and the inferior caval vein ascending to the right atrium with no extrahepatic spread. Due to several comorbidities, a systemic treatment by tyrosine kinase inhibitors was contraindicated. After discussion at the multidisciplinary hepatology tumor board, he was referred for selective internal radiation therapy. Unfortunately, the work-up showed an important lung shunt not allowing radioembolization. No clear recommendations are available in this situation. The decision was made to propose a combination treatment by transarterial chemoembolization, that was performed using a new generation of radio-opaque microspheres loaded with doxorubicin, followed by immunotherapy. This allowed a complete response with a very good quality of life.

Publisher

Universa BV

Reference18 articles.

1. GALLE P. R., FORNER A., LLOVET J. M., MAZZAFERRO V., PISCAGLIA F., RAOUL J. L. et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018, 69(1) : 182-236.

2. LEFERE S., DEVISSCHER L., GEERTS A. Angiogenesis in the progression of non-alcoholic fatty liver disease. Acta Gastroenterol. Belg. 2020, 83(2) : 301-307.

3. FRANCQUE S., LANTHIER N., VERBEKE L., REYNAERT H., VAN STEENKISTE C., VONGHIA L. et al. The Belgian Association for Study of the Liver Guidance Document on the Management of Adult and Paediatric Non-Alcoholic Fatty Liver Disease. Acta Gastroenterol. Belg. 2018, 81(1) : 55-81.

4. HEIMBACH J. K., KULIK L. M., FINN R. S., SIRLIN C. B., ABECASSIS M., ROBERTS L. R. et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018, 67(1) : 358-380.

5. FORNER A., REIG M., BRUIX J. Hepatocellular carcinoma. Lancet. 2018, 391(10127) : 1301-1314.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3